Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy

被引:18
|
作者
Vijande, Javier [1 ,2 ]
Ballester, Facundo [1 ]
Ouhib, Zoubir [3 ]
Granero, Domingo [4 ]
Carmen Pujades-Claumarchirant, M. [5 ]
Perez-Calatayud, Jose [5 ]
机构
[1] Univ Valencia, Dept Atom Mol & Nucl Phys, E-46100 Burjassot, Spain
[2] Univ Valencia, CSIC, IFIC, Paterna, Valencia, Spain
[3] Boca Raton Reg Hosp, Lynn Canc Inst, Boca Raton, FL USA
[4] Hosp Gen Univ, ERESA, Dept Radiat Phys, Valencia, Spain
[5] La Fe Univ Hosp, Dept Radiat Oncol, Valencia, Spain
关键词
Ir-192; Brachytherapy; Dosimetry; Penelope2008; Freiburg flap; PARAMETERS; IR-192; APPLICATORS;
D O I
10.1016/j.brachy.2011.11.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the one predicted by the treatment planning system (TPS) using the TG-43 dose-calculation formalism. METHODS AND MATERIALS: Monte Carlo (MC) simulations and radiochromic film measurements have been performed to obtain dose distributions with the source located at the center of one of the spheres and between two spheres. Primary and scatter dose contributions were evaluated to understand the role played by the scatter component. A standard treatment plan was generated using MC- and TG-43-based TPS applying the superposition principle. RESULTS: The MC model has been validated by performing additional simulations in the same conditions but transforming air and Freiburg flap materials into water to match TG-43 parameters. Both dose distributions differ less than 1%. Scatter defect compared with TG-43 data is up to 15% when the source is located at the center of the sphere and up to 25% when the source is between two spheres. Maximum deviations between TPS- and MC-based distributions are of 5%. CONCLUSIONS: The deviations in the TG-43-based dose distributions for a standard treatment plan with respect to the MC dose distribution calculated taking into account the composition and shape of the applicator and the surrounding air are lower than 5%. Therefore, this study supports the validity of the TPS used in clinical practice. (C) 2012 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:528 / 535
页数:8
相关论文
共 50 条
  • [31] High-dose-rate brachytherapy in uterine cervix carcinoma: a comparison of dosimetry and clinical outcomes among three fractionation schedules
    Wu, Haiyan
    He, Yanan
    Chen, Duke
    Liu, Mei
    Zhao, Xiujuan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [32] Dosimetric comparison between three dimensional treatment planning system, Monte Carlo simulation and gel dosimetry in nasopharynx phantom for high dose rate brachytherapy
    Fazli, Zeynab
    Sadeghi, Mahdi
    Zahmatkesh, M. H.
    Mahdavi, Seied Rabei
    Tenreiro, Claudio
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2013, 9 (03) : 402 - 409
  • [33] Dosimetric comparison of Acuros™ BV with AAPM TG43 dose calculation formalism in breast interstitial high-dose-rate brachytherapy with the use of metal catheters
    Sinnatamby, Mourougan
    Nagarajan, Vivekanandan
    Reddy, Sathyanarayana
    Karunanidhi, Gunaseelan
    Singhavajala, Vivekanandam
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2015, 7 (04) : 273 - 279
  • [34] Dosimetric comparison between microSelectron iridium-192 and flexi cobalt-60 sources in high-dose-rate brachytherapy using Geant4 Monte Carlo code
    Gebremariam, Tsige Yhidego
    Geraily, Ghazale
    Jassim, Hussam Hameed
    Gholami, Somayeh
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2023, 15 (02) : 141 - 147
  • [35] Dose modification factors for 192Ir high-dose-rate irradiation using Monte Carlo simulations
    Kassas, Bassel
    Mourtada, Firas
    Horton, John L.
    Lane, Richard G.
    Buchholz, Thomas A.
    Strom, Eric A.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2006, 7 (03): : 28 - 34
  • [36] Dosimetric characterization of a high dose rate 192I source for brachytherapy application using Monte Carlo simulation and benchmarking with thermoluminescent dosimetry
    Bidmeshki, N. Babaei
    Sohrabpour, M.
    Mahdavi, S. R.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2014, 12 (03): : 265 - 270
  • [37] A quantitative three-dimensional dose attenuation analysis around Fletcher-Suit-Delclos due to stainless steel tube for high-dose-rate brachytherapy by Monte Carlo calculations
    Parsai, E. Ishmael
    Zhang, Zhengdong
    John, J. Feldmeier
    BRACHYTHERAPY, 2009, 8 (03) : 318 - 323
  • [38] High-dose-rate brachytherapy using Leipzig applicators for non-melanoma localized skin cancer
    Assis Pellizzon, Antonio Cassio
    Fogaroli, Ricardo
    Chen, Michael Jenwei
    Maia, Polyana
    Gondim, Guilherme
    Guedes, Douglas de Castro
    Ramos, Henderson
    Gobo Silva, Maria Leticia
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (05) : 435 - 440
  • [39] Dosimetry of indigenously developed Ir-192 high-dose rate brachytherapy source: An EGSnrc Monte Carlo study
    Sahoo, Sridhar
    Selvam, T. Palani
    Sharma, S. D.
    Das, Trupti
    Dey, A. C.
    Patil, B. N.
    Sastri, K. V. S.
    JOURNAL OF MEDICAL PHYSICS, 2016, 41 (02) : 115 - 122
  • [40] Interstitial brachytherapy for lip carcinomas: Comparison between Ir-192 low-dose-rate and high-dose-rate treatment
    Cuenin, M.
    Salleron, J.
    Peiffert, D.
    Meknaci, E.
    Gallet, P.
    Abushama, Y.
    Py, J. -F
    Renard, S.
    CANCER RADIOTHERAPIE, 2024, 28 (02): : 145 - 151